Juvena Therapeutics
Juvena Therapeutics, Inc.
Juvena Therapeutics is a biotechnology startup that utilizes a sophisticated artificial intelligence platform to discover and develop novel protein-based therapeutics. The company focuses on mining the secretomes of stem cells to identify secreted proteins that can promote tissue regeneration and repair, aiming to treat age-related and chronic degenerative diseases. Their strategy involves advancing their own drug pipeline while also forming strategic partnerships with larger pharmaceutical companies.
Products & Team
JuvNET AI Platform
JuvNET is an AI-enabled computational platform designed to map the therapeutic potential of thousands of secreted proteins sourced from human stem cells. It integrates and analyzes large datasets from proteomics, transcriptomics, and high-content imaging to predict the function of these proteins and their regenerative effects on various cell types and diseases.
The platform addresses the slow, high-risk nature of traditional drug discovery by systematically identifying and validating novel, potent protein-based drug candidates from a vast and complex biological source.
For pharmaceutical partners, the platform addresses the high cost and failure rate of traditional drug discovery pipelines. For patients, Juvena's therapeutics aim to provide effective treatments for progressive, debilitating diseases like Myotonic Dystrophy Type 1 that currently have limited options.